LEADER 03167nam 22003613 450 001 9910874660703321 005 20240716080257.0 010 $a9783031598661 035 $a(CKB)32775325500041 035 $a(MiAaPQ)EBC31526166 035 $a(Au-PeEL)EBL31526166 035 $a(EXLCZ)9932775325500041 100 $a20240716d2024 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 14$aThe Major Histocompatibility Complex (MHC/ HLA) in Medicine $eA Personal Recollection 205 $a1st ed. 210 1$aCham :$cSpringer International Publishing AG,$d2024. 210 4$d©2024. 215 $a1 online resource (116 pages) 311 08$a9783031598654 327 $aIntro -- Acknowledgments -- About This Book -- Contents -- About the Author -- 1: The Discovery of the Major Histocompatibility Complex (MHC): The H-2 in Mice and the HLA in Man -- 1.1 The H-2 System -- 1.2 The HLA System -- 1.2.1 The HLA International Workshops -- References -- 2: The Discovery of the Biological Function of the MHC -- 2.1 T Lymphocyte Killing Restricted by MHC -- 2.2 The Discovery of Natural Killer Cells -- References -- 3: HLA Genes and Molecules -- 3.1 Genomic Organization of the HLA System -- 3.2 Molecular Structure of HLA Class-I and Class-II -- 3.2.1 HLA Class-I -- 3.2.2 HLA Class-II -- 3.3 Cellular and Tissue Expression of HLA Molecules -- 3.4 Antigen Processing and Presentation to T Lymphocytes -- 3.4.1 Antigen Presentation to CD8+ T Lymphocytes -- 3.4.2 Antigen Presentation to CD4+ T Lymphocytes -- 3.5 The Different Recognition of HLA Class-I Molecules by Cytotoxic CD8+ T Lymphocytes and NK Cells -- References -- 4: HLA in Transplantation -- 4.1 HLA in Kidney Transplantation -- 4.2 HLA in Bone Marrow Transplantation -- 4.3 The Human Leucocyte Differentiation Antigens (HLDA) Workshops: Their Impact in Transplantation -- References -- 5: MHC/HLA Class-I Loss and Cancer Immune Escape -- 5.1 The Discovery of Tumour Antigens Recognized by T Lymphocytes -- 5.2 The Discovery of MHC Class-I Loss in Tumours -- 5.2.1 Altered HLA Class-I Tumour Phenotypes -- 5.2.2 The Transition From HLA Class-I Positive to HLA Class-I Negative Tumours During Cancer Progression -- 5.2.3 HLA Class-I Expression in Metastatic Nodes -- 5.2.4 HLA Class-I Losses and Cancer Immunotherapy -- References -- 6: HLA and Disease Association -- 6.1 Diseases Associated with HLA Class-I and Class-II -- 6.1.1 Ankylosing Spondylitis (AS) -- 6.1.2 Celiac Disease -- 6.1.3 Insulin-Dependent Type-1 Diabetes (IDD) -- 6.1.4 Narcolepsy. 327 $a6.1.5 Rheumatoid Arthritis -- 6.2 Conclusion -- References -- 7: HLA in Population Genetics -- 7.1 HLA and Human Migrations -- 7.2 Generation of HLA Diversity and Selection of HLA Alleles by Pathogens -- References -- Concluding Remarks. 700 $aGarrido$b Federico$0995416 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 912 $a9910874660703321 996 $aThe Major Histocompatibility Complex (MHC$94183988 997 $aUNINA